"Unlike other retailers, we are in a speacialised category of health and it is growing in India. The nutrition market alone is about USD 2 billion, growing at 22-25 per cent.
"Health and devices with products like glucose testing kits and blood pressure monitors, is a USd 3-5 billion market in India," HealthKart co-founder and Managing Director Prashant Tandon told PTI on the sidelines of the Technopak Leadership Forum, E-tailing 2014.
"Add to that the wellness market. People in the country today are more informed and concerned about what they consume. This alone is a USD 10-15 billion market," he said.
The company, which has about 350 employees, has so far raised about USD 22.5 billion in three rounds of funding. Its investors include Sequoia, Intel Capital, Kae Capital and Omidyar Network. Tandon declined to comment on revenue details.
More From This Section
Asked if the firm was looking at raising more funds, Tandon said HealthKart has been receiving interest but it is yet to finalise anything.
The firm, which also operates a drug search app called HealthKart Plus, said over 30 per cent of its sales is coming from smaller towns.
"A major problem that the small towns faced was the unavailability of health products and that of fakes. People don't mind fakes with apparel but will not take the risk with their health. We work directly with the brands and their authorised distributors to ensure that they get only genuine products," he said.
Through HealthKart Plus, the company offers information on prescribed medicines, substitutes, usage and also direct users to the nearest drug stores where it will be available. The app has already has 750,000 users.